Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade (Q33410126)

26 July 2017

Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade (English)

1 reference

26 July 2017

6

Claus Belka

1 reference

26 July 2017

Maximilian Niyazi

1

1 reference

26 July 2017

Patrizia Marini

2

1 reference

26 July 2017

Peter T Daniel

3

1 reference

26 July 2017

Robin Humphreys

4

1 reference

26 July 2017

Verena Jendrossek

5

1 reference

26 July 2017

1 January 2009

1 reference

Strahlentherapie und Onkologie

26 July 2017

1 reference

26 July 2017

185

1 reference

26 July 2017

8-18

1 reference

26 July 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s00066-009-1856-4

26 July 2017

0 references

cites work

Guardians of cell death: the Bcl-2 family proteins

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00066-009-1856-4

TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00066-009-1856-4

Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase

21 January 2018

1 reference

12 December 2020

[Death inducing ligands in combination with ionizing radiation: objective and current knowledge].

1 reference

12 December 2020

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

1 reference

12 December 2020

Counting colonies of clonogenic assays by using densitometric software

1 reference

12 December 2020

Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results

1 reference

12 December 2020

Pretreatment proliferation and local control in bladder cancer after radiotherapy with or without concurrent chemotherapy

1 reference

12 December 2020

ZD1839 (Gefitinib, 'Iressa'), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma.

1 reference

12 December 2020

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

12 December 2020

Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I study

1 reference

12 December 2020

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

1 reference

12 December 2020

Epidermal growth factor receptor inhibition strategies in oncology

1 reference

12 December 2020

The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro

1 reference

12 December 2020

EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: differential response of cancer stem cells and nontumourigenic cells?

1 reference

12 December 2020

Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics

1 reference

12 December 2020

HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo

1 reference

12 December 2020

The Akt pathway: molecular targets for anti-cancer drug development

1 reference

12 December 2020

Isobologram analysis of triple therapies

1 reference

12 December 2020

Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology

1 reference

12 December 2020

Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.

1 reference

12 December 2020

Apoptosis, p53, and tumor cell sensitivity to anticancer agents

1 reference

12 December 2020

Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.

1 reference

12 December 2020

Combined effect of tumor necrosis factor-alpha and ionizing radiation on the induction of apoptosis in 5637 bladder carcinoma cells

1 reference

12 December 2020

Development and clinical indications of cetuximab.

1 reference

12 December 2020

Integration of novel agents into combined-modality treatment for rectal cancer patients

1 reference

12 December 2020

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

12 December 2020

The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target

1 reference

12 December 2020

Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo

1 reference

12 December 2020

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

12 December 2020

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

12 December 2020

Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinoma.

1 reference

12 December 2020

Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis

1 reference

12 December 2020

EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms

1 reference

12 December 2020

Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies.

1 reference

12 December 2020

Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis

1 reference

12 December 2020

Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer

1 reference

12 December 2020

Targeted cancer therapies based on antibodies directed against epidermal growth factor receptor: status and perspectives

1 reference

12 December 2020

Radiosensitivity of tumor cell lines after pretreatment with the EGFR tyrosine kinase inhibitor ZD1839 (Iressa).

1 reference

12 December 2020

Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy.

1 reference

12 December 2020

Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL

1 reference

12 December 2020

Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells

1 reference

12 December 2020

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Role of BAX in the apoptotic response to anticancer agents

1 reference

12 December 2020

Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity

1 reference

12 December 2020

Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model

1 reference

12 December 2020

10.1007/S00066-009-1856-4

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference